Umanis   Report issue

For profit Phase 1 Phase 4
Founded: Levallois-perret France (1990)
Status: No NME R&D (1990)

Organization Overview

First Clinical Trial
2005
NCT00351949
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

etanercept (enbrel) (1 trial)

Drugs in Phase 1 Trials (1)

lag-3 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Breast Neoplasms (Phase 1)

Carcinoma (Phase 1)

Carcinoma, Renal Cell (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2